T
MRK icon

TOBAM’s Merck MRK Stock Holding History

TOBAM’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Sell
5,587
-7,176
-56% -$840K 0.17% 121
2026
Q1 		$1.53M Sell
12,763
-5,666
-31% -$654K 0.4% 64
2025
Q4 		$1.94M Sell
18,429
-7,414
-29% -$696K 0.48% 61
2025
Q3 		$2.17M Sell
25,843
-22,884
-47% -$1.88M 0.79% 51
2025
Q2 		$3.86M Sell
48,727
-8,861
-15% -$704K 1.51% 26
2025
Q1 		$5.17M Sell
57,588
-7,566
-12% -$706K 2.21% 11
2024
Q4 		$6.48M Sell
65,154
-43,947
-40% -$4.53M 1.98% 12
2024
Q3 		$12.4M Sell
109,101
-381
-0.3% -$45.3K 2.26% 10
2024
Q2 		$13.6M Sell
109,482
-98,864
-47% -$12.7M 2.13% 12
2024
Q1 		$27.5M Sell
208,346
-99,582
-32% -$12.3M 2.46% 12
2023
Q4 		$33.6M Sell
307,928
-47,419
-13% -$4.92M 2.94% 2
2023
Q3 		$36.6M Buy
355,347
+1,199
+0.3% +$129K 2.94% 2
2023
Q2 		$40.9M Sell
354,148
-62,424
-15% -$7.09M 3.08% 1
2023
Q1 		$44.3M Buy
416,572
+506
+0.1% +$54.6K 2.92% 2
2022
Q4 		$46.2M Sell
416,066
-61,245
-13% -$6.26M 3.06% 2
2022
Q3 		$41.1M Sell
477,311
-496
-0.1% -$44.3K 2.87% 1
2022
Q2 		$43.6M Buy
477,807
+119,071
+33% +$10.6M 2.73% 4
2022
Q1 		$29.4M Buy
358,736
+303,285
+547% +$23.9M 1.48% 22
2021
Q4 		$4.25M Buy
55,451
+46,957
+553% +$3.74M 0.19% 90
2021
Q3 		$638K Hold
8,494
– – 0.03% 139
2021
Q2 		$661K Sell
8,494
-408
-5% -$30.3K 0.03% 140
2021
Q1 		$655K Sell
8,902
-509
-5% -$37.5K 0.03% 132
2020
Q4 		$735K Buy
9,411
+319
+4% +$24.4K 0.03% 130
2020
Q3 		$720K Buy
+9,092
New +$712K 0.04% 123
2018
Q2 		– Sell
-24,808
Closed -$1.29M – 156
2018
Q1 		$1.29M Buy
+24,808
New +$1.34M 0.05% 135
2014
Q3 		– Sell
-102,788
Closed -$5.67M – 139
2014
Q2 		$5.67M Buy
+102,788
New +$5.61M 0.25% 74

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TOBAM's MRK Position: Q2 2026 in Review

TOBAM reduced its Merck (MRK) stake by 56% in Q2 2026, selling an estimated $840K and leaving 5,587 shares worth $718K. The position accounts for 0.17% of the portfolio, ranked #121.

TOBAM first reported a position in MRK in Q2 2014 and has held it in 26 quarters since. The position peaked at $46.2M in Q4 2022. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TOBAM held 5,587 shares of Merck worth $718K as of Q2 2026.
  • TOBAM sold 7,176 Merck shares in Q2 2026, an estimated $840K.
  • Merck made up 0.17% of TOBAM's portfolio in Q2 2026, its #121 holding.
  • TOBAM first reported a position in Merck in Q2 2014 and has held it in 26 quarters since.
  • TOBAM's Merck position peaked at $46.2M in Q4 2022.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.